Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Marisa Cabeza, Yvonne Heuze, Araceli Sánchez, Mariana Garrido & Eugene Bratoeff. (2015) Recent advances in structure of progestins and their binding to progesterone receptors. Journal of Enzyme Inhibition and Medicinal Chemistry 30:1, pages 152-159.
Read now
Read now
Caroline Diep, Nathan Charles, C. Blake Gilks, Steve Kalloger, Peter Argenta & Carol A. Lange. (2013) Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. Cell Cycle 12:9, pages 1433-1449.
Read now
Read now
William H. Walker. (2011) Testosterone signaling and the regulation of spermatogenesis. Spermatogenesis 1:2, pages 116-120.
Read now
Read now
Articles from other publishers (48)
Janeen H. Trembley, Betsy T. Kren, Muhammad Afzal, George A. Scaria, Mark A. Klein & Khalil Ahmed. (2022) Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise. Molecular and Cellular Biochemistry 478:4, pages 899-926.
Crossref
Crossref
Yiyang Li, Wei Zhou, Xiangbing Meng, Sarina D. Murray, Long Li, Abby Fronk, Vanessa J. Lazaro-Camp, Kuo-kuang Wen, Meng Wu, Adam Dupuy, Kimberly K. Leslie & Shujie Yang. (2022) Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers 14:19, pages 4883.
Crossref
Crossref
May-Britt Firnau & Angela Brieger. (2022) CK2 and the Hallmarks of Cancer. Biomedicines 10:8, pages 1987.
Crossref
Crossref
Sailaja Kamaraju, Amy M Fowler, Elizabeth Weil, Kari B Wisinski, Thu H Truong, Martin Lehr, Lubna N Chaudhary, Yee Chung Cheng, Christopher R Chitambar, Hallgeir Rui, Douglas Yee & Carol Lange. (2021) Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology 162:8.
Crossref
Crossref
Stefania Salsano, Roberto González-Martín, Alicia Quiñonero, Silvia Pérez-Debén & Francisco Domínguez. (2021) Deciphering the Role of PGRMC1 During Human Decidualization Using an In Vitro Approach. The Journal of Clinical Endocrinology & Metabolism 106:8, pages 2313-2327.
Crossref
Crossref
Hossein Hosseinirad, Marefat Ghaffari Novin, Sedighe Hosseini, Hamid Nazarian, Zahra Safaei, Teibeh Hashemi, Shahrokh Paktinat & Zahra Shams Mofarahe. (2021) Evaluation of Expression and Phosphorylation of Progesterone Receptor in Endometrial Stromal Cells of Patients with Recurrent Implantation Failure Compared to Healthy Fertile Women. Reproductive Sciences 28:5, pages 1457-1465.
Crossref
Crossref
Suryendu Saha, Samya Dey & Somsubhra Nath. (2021) Steroid Hormone Receptors: Links With Cell Cycle Machinery and Breast Cancer Progression. Frontiers in Oncology 11.
Crossref
Crossref
Amy R. Dwyer, Thu H. Truong, Carlos Perez Kerkvliet, Kiran V. Paul, Peter Kabos, Carol A. Sartorius & Carol A. Lange. (2020) Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer. British Journal of Cancer 124:1, pages 217-227.
Crossref
Crossref
Hossein Hosseinirad, Marefat Ghaffari Novin, Sedighe Hosseini, Hamid Nazarian, Fardin Amidi, Shahrokh Paktinat, Elham Azizi & Zahra Shams Mofarahe. (2020) Effect of 1,25(OH)2-vitamin D3 on expression and phosphorylation of progesterone receptor in cultured endometrial stromal cells of patients with repeated implantation failure. Acta Histochemica 122:2, pages 151489.
Crossref
Crossref
Mauro E. Cenciarini & Cecilia J. Proietti. (2019) Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation. Steroids 152, pages 108503.
Crossref
Crossref
Merit L. Goodman, Gloria M. Trinca, Katherine R. Walter, Evangelia K. Papachristou, Clive S. D’Santos, Tianbao Li, Qi Liu, Zhao Lai, Prabhakar Chalise, Rashna Madan, Fang Fan, Mary A. Markiewicz, Victor X. Jin, Jason S. Carroll & Christy R. Hagan. (2019) Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer. The Journal of Immunology 202:10, pages 3076-3086.
Crossref
Crossref
Taylor E. Escher, Asona J. Lui, Eric S. Geanes, Katherine R. Walter, Ossama Tawfik, Christy R. Hagan & Joan Lewis-Wambi. (2019) Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor–Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis. Molecular Cancer Research 17:5, pages 1180-1194.
Crossref
Crossref
Thu H Truong, Amy R Dwyer, Caroline H Diep, Hsiangyu Hu, Kyla M Hagen & Carol A Lange. (2019) Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates. Endocrinology 160:2, pages 430-446.
Crossref
Crossref
Cecilia J. Proietti, Mauro E. Cenciarini & Patricia V. Elizalde. (2018) Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions. Steroids 133, pages 75-81.
Crossref
Crossref
Viroj Boonyaratanakornkit, Nalo Hamilton, Diana C. Márquez-Garbán, Prangwan Pateetin, Eileen M. McGowan & Richard J. Pietras. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Molecular and Cellular Endocrinology 466, pages 51-72.
Crossref
Crossref
Katherine A. Leehy, Thu H. Truong, Laura J. Mauro & Carol A. Lange. (2018) Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 176, pages 88-93.
Crossref
Crossref
Gloria M. Trinca, Merit L. Goodman, Evangelia K. Papachristou, Clive S. D’Santos, Prabhakar Chalise, Rashna Madan, Chad Slawson & Christy R. Hagan. (2017) O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. Hormones and Cancer 9:1, pages 12-21.
Crossref
Crossref
Todd P. Knutson, Thu H. Truong, Shihong Ma, Nicholas J. Brady, Megan E. Sullivan, Ganesh Raj, Kathryn L. Schwertfeger & Carol A. Lange. (2017) Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. Journal of Hematology & Oncology 10:1.
Crossref
Crossref
Qianwen Li, Ke Li, Tianyang Yang, Sheng Zhang, Yu Zhou, Zhenyu Li, Jinrong Xiong, Fangzheng Zhou, Xiaoshu Zhou, Li Liu, Rui Meng & Gang Wu. (2017) Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer. Scientific Reports 7:1.
Crossref
Crossref
Stefanie Ruhs, Nicole Strätz, Katja Quarch, Antonia Masch, Mike Schutkowski, Michael Gekle & Claudia Grossmann. (2017) Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 2. Scientific Reports 7:1.
Crossref
Crossref
Katherine R. Walter, Merit L. Goodman, Hari Singhal, Jade A. Hall, Tianbao Li, Sean M. Holloran, Gloria M. Trinca, Katelin A. Gibson, Victor X. Jin, Geoffrey L. Greene & Christy R. Hagan. (2017) Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. Molecular Cancer Research 15:10, pages 1331-1340.
Crossref
Crossref
Asona J. Lui, Eric S. Geanes, Joshua Ogony, Fariba Behbod, Jordan Marquess, Kelli Valdez, William Jewell, Ossama Tawfik & Joan Lewis-Wambi. (2017) IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Letters 399, pages 29-43.
Crossref
Crossref
Melissa Chua, Charina Ortega, Ayesha Sheikh, Migi Lee, Hussein Abdul-Rassoul, Kevan Hartshorn & Isabel Dominguez. (2017) CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals 10:4, pages 18.
Crossref
Crossref
Katherine A Leehy, Tarah M Regan Anderson, Andrea R Daniel, Carol A Lange & Julie H Ostrander. (2016) Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. Journal of Molecular Endocrinology 56:3, pages R99-R114.
Crossref
Crossref
XIAOFEN PAN, RUI MENG, ZHONGHUA YU, JINGJING MOU, SHA LIU, ZIYI SUN, ZHENWEI ZOU, GANG WU & GANG PENG. (2016) Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression. International Journal of Oncology 48:3, pages 1073-1084.
Crossref
Crossref
Lindsey S. Treviño, Michael J. Bolt, Sandra L. Grimm, Dean P. Edwards, Michael A. Mancini & Nancy L. Weigel. (2016) Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Molecular Endocrinology 30:2, pages 158-172.
Crossref
Crossref
Caroline H. Diep, Todd P. Knutson & Carol A. Lange. (2016) Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research 14:2, pages 141-162.
Crossref
Crossref
Yingfeng Zheng & Leigh C. Murphy. (2016) Regulation of Steroid Hormone Receptors and Coregulators during the Cell Cycle Highlights Potential Novel Function in Addition to Roles as Transcription Factors. Nuclear Receptor Signaling 14:1, pages nrs.14001.
Crossref
Crossref
Heidi N. Hilton, J. Dinny Graham & Christine L. Clarke. (2015) Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?. Molecular Endocrinology 29:9, pages 1230-1242.
Crossref
Crossref
Jacques Bonneterre, Emilie Hutt, Jacques Bosq, J. Dinny Graham, Matthew A. Powell, Eric Leblanc, Keiichi Fujiwara, Thomas J. Herzog, Robert L. Coleman, Christine L. Clarke, Erard M. Gilles, Alexander A. Zukiwski & Bradley J. Monk. (2015) Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus. Gynecologic Oncology 138:3, pages 663-667.
Crossref
Crossref
Caroline H Diep, Andrea R Daniel, Laura J Mauro, Todd P Knutson & Carol A Lange. (2015) Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology 54:2, pages R31-R53.
Crossref
Crossref
B. Patel, S. Elguero, S. Thakore, W. Dahoud, M. Bedaiwy & S. Mesiano. (2014) Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Human Reproduction Update 21:2, pages 155-173.
Crossref
Crossref
A R Daniel, A L Gaviglio, T P Knutson, J H Ostrander, A B D'Assoro, P Ravindranathan, Y Peng, G V Raj, D Yee & C A Lange. (2014) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:4, pages 506-515.
Crossref
Crossref
Christy R Hagan & Carol A Lange. (2014) Molecular determinants of context-dependent progesterone receptor action in breast cancer. BMC Medicine 12:1.
Crossref
Crossref
Nicole L. Moore, Dean P. Edwards & Nancy L. Weigel. (2014) Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 144, pages 471-482.
Crossref
Crossref
Todd P. Knutson & Carol A. Lange. (2014) Tracking progesterone receptor-mediated actions in breast cancer. Pharmacology & Therapeutics 142:1, pages 114-125.
Crossref
Crossref
Hany A. Abdel-Hafiz & Kathryn B. Horwitz. (2014) Post-translational modifications of the progesterone receptors. The Journal of Steroid Biochemistry and Molecular Biology 140, pages 80-89.
Crossref
Crossref
Christy R. Hagan, Todd P. Knutson & Carol A. Lange. (2013) A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research 41:19, pages 8926-8942.
Crossref
Crossref
Lindsey S. Treviño & Nancy L. Weigel. (2013) Phosphorylation: a fundamental regulator of steroid receptor action. Trends in Endocrinology & Metabolism 24:10, pages 515-524.
Crossref
Crossref
Tarah M. Regan Anderson, Danielle L. Peacock, Andrea R. Daniel, Gregory K. Hubbard, Kristopher A. Lofgren, Brian J. Girard, Alexandra Schörg, David Hoogewijs, Roland H. Wenger, Tiffany N. Seagroves & Carol A. Lange. (2013) Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression. Cancer Research 73:18, pages 5810-5820.
Crossref
Crossref
Maria Ruzzene. 2013. Protein Kinase CK2. Protein Kinase CK2
305
318
.
Thangavel Indumathi, Aathi Muthusankar, P. Shanmughavel & K. J. Rajendra Prasad. (2013) Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies. MedChemComm 4:2, pages 450.
Crossref
Crossref
David M. W. Cork, Thomas W. J. Lennard & Alison J. Tyson-Capper. (2012) Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative. Tumor Biology 33:6, pages 2329-2340.
Crossref
Crossref
A. I. Khoruzhenko. (2012) Optimization of tumor cell culture conditions in soft agar for subsequent immunohistochemical analysis. Biopolymers and Cell 28:4, pages 302-305.
Crossref
Crossref
Todd P Knutson, Andrea R Daniel, Danhua Fan, Kevin AT Silverstein, Kyle R Covington, Suzanne AW Fuqua & Carol A Lange. (2012) Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Research 14:3.
Crossref
Crossref
Alison E. Obr & Dean P. Edwards. (2012) The biology of progesterone receptor in the normal mammary gland and in breast cancer. Molecular and Cellular Endocrinology 357:1-2, pages 4-17.
Crossref
Crossref
Christy R. Hagan, Andrea R. Daniel, Gwen E. Dressing & Carol A. Lange. (2012) Role of phosphorylation in progesterone receptor signaling and specificity. Molecular and Cellular Endocrinology 357:1-2, pages 43-49.
Crossref
Crossref
Stephen R. Hammes & Ellis R. Levin. (2011) Minireview: Recent Advances in Extranuclear Steroid Receptor Actions. Endocrinology 152:12, pages 4489-4495.
Crossref
Crossref